Works matching IS 10837159 AND DT 2019 AND VI 24 AND IP 4


Results: 27
    1
    2

    Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study).

    Published in:
    Oncologist, 2019, v. 24, n. 4, p. 491, doi. 10.1634/theoncologist.2018-0787
    By:
    • Schmidinger, Manuela;
    • Bamias, Aristotelis;
    • Procopio, Giuseppe;
    • Hawkins, Robert;
    • Sanchez, Angel Rodriguez;
    • Vázquez, Sergio;
    • Srihari, Narayanan;
    • Kalofonos, Haralabos;
    • Bono, Petri;
    • Pisal, Chaitali Babanrao;
    • Hirschberg, Yulia;
    • Dezzani, Luca;
    • Ahmad, Qasim;
    • Jonasch, Eric;
    • Gimeno, Ramón Aldabó;
    • Herranz, Urbano Anido;
    • Ardavanis, Alexandros;
    • Ashraf, Safeer A;
    • Barone, Carlo;
    • Bella, Santiago R
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12

    Regulatory and Clinical Experiences with Biosimilar Filgrastim in the U.S., the European Union, Japan, and Canada.

    Published in:
    Oncologist, 2019, v. 24, n. 4, p. 537, doi. 10.1634/theoncologist.2018-0341
    By:
    • Chen, Brian;
    • Nagai, Sumimasa;
    • Armitage, James O.;
    • Witherspoon, Bartlett;
    • Nabhan, Chadi;
    • Godwin, Ashley C.;
    • Yang, Y. Tony;
    • Kommalapati, Anuhya;
    • Tella, Sri Harsha;
    • DeAngelis, Carlo;
    • Raisch, Dennis W.;
    • Sartor, Oliver;
    • Hrushesky, William J.;
    • Ray, Paul S.;
    • Yarnold, Paul R.;
    • Love, Bryan L.;
    • Norris, LeAnn B.;
    • Knopf, Kevin;
    • Bobolts, Laura;
    • Riente, Joshua
    Publication type:
    Article
    13
    14
    15
    16

    FDA Approval Summary: Atezolizumab or Pembrolizumab for the Treatment of Patients with Advanced Urothelial Carcinoma Ineligible for Cisplatin‐Containing Chemotherapy.

    Published in:
    Oncologist, 2019, v. 24, n. 4, p. 563, doi. 10.1634/theoncologist.2018-0084
    By:
    • Suzman, Daniel L.;
    • Agrawal, Sundeep;
    • Ning, Yang‐min;
    • Maher, V. Ellen;
    • Fernandes, Laura L.;
    • Karuri, Stella;
    • Tang, Shenghui;
    • Sridhara, Rajeshwari;
    • Schroeder, Jason;
    • Goldberg, Kirsten B.;
    • Ibrahim, Amna;
    • McKee, Amy E.;
    • Pazdur, Richard;
    • Beaver, Julia A.
    Publication type:
    Article
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26

    A Randomized Phase II Trial (TAMIGA) Evaluating the Efficacy and Safety of Continuous Bevacizumab Through Multiple Lines of Treatment for Recurrent Glioblastoma.

    Published in:
    Oncologist, 2019, v. 24, n. 4, p. 521, doi. 10.1634/theoncologist.2018-0290
    By:
    • Brandes, Alba A.;
    • Gil‐Gil, Miguel;
    • Saran, Frank;
    • Carpentier, Antoine F.;
    • Nowak, Anna K.;
    • Mason, Warren;
    • Zagonel, Vittorina;
    • Dubois, François;
    • Finocchiaro, Gaetano;
    • Fountzilas, George;
    • Cernea, Dana Michaela;
    • Chinot, Oliver;
    • Anghel, Rodica;
    • Ghiringhelli, Francois;
    • Beauchesne, Patrick;
    • Lombardi, Giuseppe;
    • Franceschi, Enrico;
    • Makrutzki, Martina;
    • Mpofu, Chiedzo;
    • Urban, Hans‐Joerg
    Publication type:
    Article
    27